At a Glance
- What we study: Aneurysms, dissections, and complex aortic repairs—from early detection to advanced surgical and endovascular solutions.
- How it helps you: Research translates into safer procedures, smarter imaging, and better outcomes, guided by a team that collaborates across heart and vascular care.
- Where we publish & lead: Multicenter clinical trials and publications in leading journals; co founders of the Western Aortic Collaborative (WAC) to accelerate discoveries.
Our Patient Centered Research Approach
We bring together cardiothoracic surgery, vascular surgery, radiology, cardiology, and genetics to understand aortic disease from every angle. Using advanced imaging, computational modeling, molecular biology, and surgical innovation, we move ideas from the lab to the operating room—and to your bedside.
What this means for patients
- Earlier detection & monitoring: We work on new biomarkers, imaging methods, and predictive models to identify risks sooner and tailor follow up plans.
- Innovative treatments: We study and refine open and endovascular techniques for complex aortic repairs through trials, device development, and quality improvement initiatives.
- Team based care: Our program is deeply collaborative and translational, ensuring research changes care pathways in real time.
Goals That Guide Our Work
- Early Detection & Risk Stratification
Develop and validate tools that spot aneurysms and dissections earlier—and identify who needs closer monitoring.
- Surgical & Endovascular Innovation
Improve technique and technology for complex aortic repairs, backed by clinical trials and outcome tracking.
- Education & Collaboration
Train future clinician scientists and partner across institutions (including the Western Aortic Collaborative) to speed progress that benefits patients.
Clinical Trials (Examples)
Why it matters: Trials offer access to new devices and approaches that may improve safety, recovery, and long term results. Ask your care team if a study is right for you.
- ARISE II / ARISE III: Evaluating ascending aortic stent grafts for select patients, including those with new type A dissection.
- ARTIZEN: Studying the Arcevo LSA™ Hybrid Stent Graft System for aortic arch/descending aorta disease, including dissection and aneurysm. We recently completed the first 4 implants of the Arcevo LSA™ Frozen Elephant Trunk at our institution — among the first 30 performed worldwide.
- IMPROVE AD: Comparing upfront TEVAR + medical therapy versus medical therapy with surveillance for subacute uncomplicated type B dissection.
- MRI Studies (Brain & Hemiarch): Tracking brain micro emboli and aortic flow before and after surgery to improve protection and outcomes.
Note: Trial availability changes. For current eligibility and open studies, schedule an appointment with our team.
Track Record of Impact
- Leadership in multicenter trials of stent grafts, biologic therapies, and surgical techniques.
- Hundreds of publications in top journals (e.g., Annals of Thoracic Surgery, Journal of Thoracic and Cardiovascular Surgery, Journal of Surgical Research).
- Founding member of WAC to advance techniques, mentor surgeons, and conduct multi institutional studies that answer pressing clinical questions.
- World-first milestone: First 4 implants of the Arcevo LSA™ Frozen Elephant Trunk at the University of Colorado, performed by T. Brett Reece, MD — among the first 30 implanted globally as part of the ARTIZEN trial.